company background image
LNSR

LENSAR NasdaqCM:LNSR Stock Report

Last Price

US$6.28

Market Cap

US$69.2m

7D

-1.5%

1Y

-24.2%

Updated

09 Aug, 2022

Data

Company Financials +
LNSR fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

LNSR Stock Overview

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism.

LENSAR, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for LENSAR
Historical stock prices
Current Share PriceUS$6.28
52 Week HighUS$8.98
52 Week LowUS$5.50
Beta0
1 Month Change-10.29%
3 Month Change-8.05%
1 Year Change-24.20%
3 Year Changen/a
5 Year Changen/a
Change since IPO-30.22%

Recent News & Updates

Aug 08

LENSAR GAAP EPS of -$0.67, revenue of $8M

LENSAR press release (NASDAQ:LNSR): Q2 GAAP EPS of -$0.67. Revenue of $8M (+1.3% Y/Y).  Adjusted EBITDA was -$4.3M for the quarter ended June 30, 2022 and -$2.3M for the quarter ended June 30, 2021.  As of June 30, 2022, the company had cash and cash equivalents of $25.2M as compared to $31.6M at December 31, 2021. Based on its cash position and operational forecasts, the company believes it has sufficient cash to fund operations into 2024.

Shareholder Returns

LNSRUS Medical EquipmentUS Market
7D-1.5%-0.6%0.3%
1Y-24.2%-21.4%-13.5%

Return vs Industry: LNSR underperformed the US Medical Equipment industry which returned -21.3% over the past year.

Return vs Market: LNSR underperformed the US Market which returned -13% over the past year.

Price Volatility

Is LNSR's price volatile compared to industry and market?
LNSR volatility
LNSR Average Weekly Movement4.6%
Medical Equipment Industry Average Movement9.6%
Market Average Movement7.9%
10% most volatile stocks in US Market17.2%
10% least volatile stocks in US Market3.2%

Stable Share Price: LNSR is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: LNSR's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2004110Nick Curtishttps://www.lensar.com

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

LENSAR, Inc. Fundamentals Summary

How do LENSAR's earnings and revenue compare to its market cap?
LNSR fundamental statistics
Market CapUS$69.21m
Earnings (TTM)-US$23.49m
Revenue (TTM)US$36.87m

1.9x

P/S Ratio

-2.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
LNSR income statement (TTM)
RevenueUS$36.87m
Cost of RevenueUS$17.81m
Gross ProfitUS$19.07m
Other ExpensesUS$42.56m
Earnings-US$23.49m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-2.13
Gross Margin51.71%
Net Profit Margin-63.71%
Debt/Equity Ratio0%

How did LNSR perform over the long term?

See historical performance and comparison